3.97MMarket Cap-706P/E (TTM)
0.575High0.490Low115.15KVolume0.483Open0.507Pre Close60.15KTurnover2.40%Turnover RatioLossP/E (Static)7.61MShares2.71052wk High1.55P/B2.51MFloat Cap0.40052wk Low--Dividend TTM4.81MShs Float7.720Historical High--Div YieldTTM16.78%Amplitude0.400Historical Low0.522Avg Price1Lot Size
Lipella Pharmaceuticals Stock Forum
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evalua...
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
3 MINUTES AGO, 8:00 AM EST
VIA GLOBENEWSWIRE
$Lipella Pharmaceuticals(LIPO.US)$
double bottom?
$XBP Europe Holdings(XBP.US)$
$Volato Group(SOAR.US)$
$Meiwu Technology(WNW.US)$
$Lipella Pharmaceuticals(LIPO.US)$ Lipella
No comment yet